Objective: Pneumococcal surface protein A (PspA) is present in almost all strains of pneumococci and is highly immunogenic, stimulating the production of antibodies. It has a role in pneumococcal pathogenicity. This study aimed to determine some immunological and physicochemical properties of PspA using bioinformatics software. Also, an in silico study was applied to clone the pspA gene by ligating it into pCRII-TOPO and transferring it into E. coli Bl21.Materials and Methods: PspA (WP_368082102) and pspA (U89711) were extracted from NCBI. The programs performed in this work included: PSIPRED, MemBrain 3.1, XtalPred, FUpred, CoCoPRED, Signal-CF, EzyPred, OSML, C-IMMSIM, Geneious Prime, AMUSER 1.0, PyMOL, and CCP4MG. Results: PspA has 5 distinct bound ary domains and 8 coiled-coil domain (CCD) network. FU-score values were found between residues 430-540 and 780-810. Antibody production (IgM+ IgG) commences on the fifth day of infection. The IFN-g reached high peak concentration and stabilized between days 12 and 17, followed by IL-23. The pspA was successfully ligated in pCRII-TOPO and cloned in E. coli BL21. Conclusions: The PspA lacks enzymatic activity, which may pave the path for future research into developing an anti-PspA vaccination or discovering a medication that may negate its effects

Background: This analysis investigates invasion tactics of Anaplasma phagocytophilum which constitutes a gram-negative bacterial species that causes the tick-borne pathogen known as human granulocytic anaplasmosis (HGA).
Aim: This study analyzes structural and molecular dynamic aspects of invasion proteins AipA and OmpA by computational means. These scientific analyzes investigate bacterial adhesion and invasion mechanisms and their receptor-specific bonds to CD13 and Sialyl Lewis x. Materials: SOPMA, VADAR 1.8, MapPred and trRosetta were used to determine secondary and tertiary structures of AipA and OmpA. The docking simulations conducted with AutoDock Vina and HDOCK identified interaction areas between AipA and CD13 and also between OmpA with Sialyl Lewis x. The analysis of residue interactions helped identify the binding sites through visual representation of their dynamical patterns.
Results: The compact AipA exhibits four critical residues SER82 and THR91 and ILE150 and PHE155 that enable stable connection with CD13 host receptors. The receptor-mediated internalization process depends on the stable structural configuration of this molecule. The ability of OmpA to bind Sialyl Lewis x effectively stems from flexible composition elements GLU160 and LYS45 and HIS87 which create operative flexibility. The ability of OmpA to adapt its interactions follows both hydrogen bonds and hydrophobic contact establishment patterns. Molecular docking analysis demonstrates that AipA maintains strong binding stability through tight binding interactions yet OmpA shows moderate binding affinity along with flexibility towards different receptor conformations. The analysis establishes how AipA and OmpA use different methods to facilitate their interactions between pathogens and hosts.
Conclusions: The outcomes create opportunities to develop targeted medical approaches targeted at adhesion and invasion blockage thus requiring experimental verification for future application.